Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for.

Slides:



Advertisements
Similar presentations
© 2009 NHS National Genetics Education and Development CentreGenetics and Genomics for Healthcare Inherited Pre-disposition.
Advertisements

Hereditary aspects of upper GI malignancy Eamonn Sheridan Consultant in Clinical Genetics.
This short questionnaire will help to determine whether there may be a gene in your family connected to an increased risk of the development of bowel.
Familial adenomatous polyposis
Hereditary GI Cancer-a Primer for Medical Oncologists
The Human Genome 23 Pairs of Chromosomes About 30,000 Genes.
Pathophysiology Colon CA. Most colorectal cancers, regardless of etiology, arise from adenomatous polyps. Polyp - a grossly visible protrusion from the.
Universal Screening for Lynch Syndrome
Hereditary GI Cancer Syndromes: Keys to identify high risk patients
Suggestions for PMS2 best practice Jenny Simmonds
HNPCC and FAP are both associated with familial colon cancer but differ in many aspects. Describe the similarities and differences between these conditions.
1 An Update on Evolving Colorectal Screening Issues May 19, 2011 This first part today will be presented by: Stanley H. Weiss, MD, FACP, FACE  Professor,
Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Lynch Syndrome and Colorectal Cancer Steven G. Proshan, M.D. Annapolis Colon and Rectal Surgeons Anne Arundel Medical Center November 8,
Screening for Colorectal Cancer Cancer Symposium: Measuring the Benefits of Screening and Treatment October 2007.
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
COLORECTAL BLEEDING: a multidisciplinary approach Torino, 31 marzo-1 aprile 2006 GENETIC EVALUATION Schena M, Angelini F, Bertetto O. Department of Medical.
Hereditary Colon Cancer ACP, October 2013 Steve Lanspa MD, FACP.
Lecture 22 Cancer Genetics II: Inherited Susceptibility to Cancer Stephen B. Gruber, MD, PhD November 19, 2002.
Mechanisms and Epidemiology of Colon Cancer
Hereditary Colorectal Cancer: An Overview Felice Schnoll-Sussman,MD Jay Monahan Center for Gastrointestinal Health New York Hospital/ Weill Cornell Medical.
About these slides SPEC – Short Presentation in Emerging Concepts
Familial Colorectal Cancers Francis M. Giardiello, M.D. The Johns Hopkins University.
Comprehensive IHC Screening for Lynch Syndrome: What You Need to Know Andrea Lewis, MS, CGC January 14, 2010.
Kalyani Maganti, M.D. ASCO Chromosomes, DNA, and Genes Cell Nucleus Chromosomes Gene Protein.
Morning Report May 20, 2009 Bridger Clarke  Born in Lawrence, Massachusetts, on 4 January  Dropped out of high school at the age of fourteen.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
Immunohistochemistry (IHC) for Microsatellite Instability Fact Sheet Frequently Asked Questions What is Lynch Syndrome? Lynch syndrome is a hereditary.
Genetics & Colorectal Cancer
Autosomal dominant inheritance Risks to children where both parents are affected: the basics a tutorial to show how the genes segregate to give the typical.
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center.
ANDREW LATCHFORD BSc, MBBS, MD, FRCP CONSULTANT GASTROENTEROLOGIST
Colorectal carcinoma Dr.Mohammadzadeh.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
 FAP - familial adenomatous polyposis  germline mutations in the APC gene (“gatekeeper”)  HNPCC - hereditary nonpolyposis colon cancer (a.k.a. Lynch.
Adult-Onset Disease The Example of Colon Cancer Summer, 2012.
Amber Ellis and Russell Brown
Tumour Analysis-Lynch Syndrome Dr Alan Donaldson Consultant in Clinical Genetics Bristol.
סרטן מעי גס אבחון מוקדם מניעה טיפול מונע ד"ר הוברט אילה מנהלת המרכז לגידולים במערכת העיכול מכון שרת הדסה עין כרם.
Uterine Cancer Endometrial (or uterine) cancer will account for 50,000 new cases and 8200 deaths in the United States in Two genetic disorders are.
MSH2 and Hereditary Nonpolyposis Colorectal Cancer By Bobby Glenn Warren III.
Slides last updated: March 2015 CRC: RISK FACTORS.
Variable gene expression in APC- and MUTYH mutation negative FAP and AFAP patients Rohlin A* 1, Wernersson J 1, Björk J 2, and Nordling M 1 Dept of Clinical.
Pancreatic Cancer In 2012 there were 43,920 cases of pancreatic cancer. 10% of these cases have a family clustering of pancreatic cancers and associated.
Definition Signs & symptoms Treatment Root of the disease.
Do you have 3 or more affected relatives? (2 or less)
Date of download: 5/31/2016 From: The Hereditary Nonpolyposis Colorectal Cancer Syndrome: Genetics and Clinical Implications[dhelix] Ann Intern Med. 2003;138(7):
Colon Cancer in-house Database (Atlantic Project) Enrico Capobianco Simone Carcangiu Massimiliano Orsini Antonella Travaglione Lucila Machado Kim Jihonn.
Lynch Syndrome or Hereditary Non-Polyposis Colorectal Cancer (HNPCC)
TPMI Research Day October 8th, 2015
Institute of Biomedical & Genetic Engineering (IBGE)
Cancer Can Not Comfort But Your Family Can
Irritable Bowel Syndrome
FAMILIAL ADENOMATOUS POLYPOSIS
Hereditary Colon Cancer Syndromes
Genomic Instability and Cancer
11/29/ /29/2018 Dr Zeinalian.
Hereditary and Familial Colon Cancer
Noralane M Lindor  Clinical Gastroenterology and Hepatology 
Short Presentations in Emerging Concepts (SPEC)
Colonic polyps and tumors
Specific Tumor Suppressor Genes
Familial Colorectal Cancer, Beyond Lynch Syndrome
Supporting Patients With Colorectal Cancer
A, Proportion of variants detected in the MMR genes.
Hereditary Cancer Syndromes—A Primer on Diagnosis and Management, Part 2: Gastrointestinal Cancer Syndromes  N. Jewel Samadder, MD, MSc, Noemi Baffy,
Presentation transcript:

Colon Cancer The life time risk of developing Colon Cancer in the United States in one in sixteen. This means 144,000 new cases a year accounting for 9% of all cancers. 10% of colon cancers have a genetic background. The risk for developing colon cancer increases with age, climbing rapidly after age 50 and rare before age 40.

Various criteria have been published to try and define “high risk” groups. Even the best collection of clinical findings such as the revised Bethesda criteria will miss as many as 20% of the cases. Presently the search for inherited colon cancer is proceeding down two lines of investigation, microsatellite instability and clinical findings.

Microsatellites are DNA base pair repeats that are present throughout the human genome. If they are altered or “unstable” then there is a chance that other areas in the DNA could also be altered or mutated. In general, colon cancers that are unstable or Microsatellite High(MSI high) are associated with Lynch Syndrome. Not all MSI-high colon cancers are hereditary. 15% of all colon cancers are MSI-high and in this group between 3 and 5% are associated with Lynch Syndrome. Lynch Syndrome is a group of disorders that share the same mechanism and that is a faulty repair of misspellings of the DNA - either one, or up to three base pairs at a time.

One of four enzymes are mutated in Lynch Syndrome - MLH1, MSH2, MSH6, and PMS2

Patients with Lynch Syndrome are at increased risk for the following cancers

The classic hallmark for Lynch Syndrome has been, right sided colon cancers, young age (under 50), multiple generations of colon cancer or other lynch syndrome associated cancers, multiple cancers in one individual, and improved survival once diagnosed. Ohio State University screens ALL colorectal cancer patients regardless of the above criteria and found the incidence to be 7%. They found cases of Lynch syndrome in patients in their 70’s, left sided cancers, and little or no other family members with colon or Lynch related cancers.

This has lead to a national movement to screen all colon cancers for Lynch. In Peoria your cancer can be checked for Microsatellite stability and the presence or absence of the Lynch associated enzymes. Based on these results you can be tested for a specific mutation to see if you are carrying one of these mutated genes.

The other group of hereditary colon cancer syndromes are associated with Microsatellite “stable” cancers. These include: a) Familial Adenomatous Polyposis (FAP) b) Attenuated Familial Adenomatous Polyposis (AFAP) c) Juvenile Polyposis d) MUTYH associated polyposis (MAP) e) Peutz-Jeghers syndrome Each disorder has a clinical picture and a specific genetic marker.

There are other syndromes associated with colon cancer, such as Serrated Polyposis Syndrome - a collection of a special type of polyps. There is no marker for this disorder, but it carries an increased risk of colorectal cancer. If you would like to discuss your family history and colon cancer please make an appointment to see us in our genetics clinic.